Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
58.46
-0.12 (-0.20%)
Mar 23, 2026, 4:00 PM EDT - Market closed

Haemonetics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21
2,7173,0474,3354,1753,2645,699
Market Cap Growth
-21.28%-29.71%3.84%27.89%-42.73%12.19%
Enterprise Value
3,5783,9654,9644,6563,7786,215
Last Close Price
58.4663.1985.3582.7563.85112.04
PE Ratio
16.0119.0937.2736.9476.0172.28
Forward PE
11.3213.2120.4925.4523.8233.88
PEG Ratio
1.031.001.392.421.362.46
PS Ratio
2.062.243.313.573.296.55
PB Ratio
3.003.714.525.104.367.79
P/TBV Ratio
3.093.914.575.204.387.85
P/FCF Ratio
8.8221.3930.1851.0843.0979.42
P/OCF Ratio
8.0216.7723.8515.2918.9552.38
EV/Sales Ratio
2.712.913.793.983.807.14
EV/EBITDA Ratio
9.8111.7518.9418.6721.1735.71
EV/EBIT Ratio
13.8217.8730.1029.8446.7969.25
EV/FCF Ratio
11.6127.8334.5656.9749.8886.60
Debt / Equity Ratio
1.341.490.840.941.030.97
Debt / EBITDA Ratio
3.373.633.083.074.334.07
Debt / FCF Ratio
3.988.605.629.3710.219.86
Net Debt / Equity Ratio
0.951.120.660.590.690.70
Net Debt / EBITDA Ratio
2.372.722.401.932.882.96
Net Debt / FCF Ratio
2.806.454.385.896.797.18
Asset Turnover
0.520.590.630.620.540.56
Inventory Turnover
1.571.792.142.001.581.59
Quick Ratio
1.040.881.281.840.951.26
Current Ratio
1.751.622.563.061.712.74
Return on Equity (ROE)
19.30%18.83%13.22%14.72%5.86%12.05%
Return on Assets (ROA)
7.72%7.55%6.18%6.71%2.99%6.34%
Return on Invested Capital (ROIC)
9.39%9.04%7.54%8.45%3.64%7.64%
Return on Capital Employed (ROCE)
11.87%11.77%9.22%10.07%5.41%7.02%
Earnings Yield
6.46%5.24%2.68%2.71%1.32%1.38%
FCF Yield
11.34%4.68%3.31%1.96%2.32%1.26%
Buyback Yield / Dilution
5.87%7.45%-0.03%1.63%-0.20%-0.18%
Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q